| Title |
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, May 2013
|
| DOI | 10.1007/s00228-013-1491-y |
| Pubmed ID | |
| Authors |
Mikael Hoffmann |
| Abstract |
During the last five decades drug and therapeutics committees (DTCs), have evolved from mainly hospital-based groups of experts in pharmacotherapy and drug logistics into an arena for healthcare professionals employing evidence-based methods of promoting rational drug use. The purpose of this study was to suggest a framework for analysing the structure and activities of DTCs. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 77 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 23% |
| Researcher | 11 | 14% |
| Student > Ph. D. Student | 8 | 10% |
| Other | 5 | 6% |
| Student > Postgraduate | 5 | 6% |
| Other | 13 | 17% |
| Unknown | 17 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 25% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 12% |
| Social Sciences | 5 | 6% |
| Business, Management and Accounting | 4 | 5% |
| Agricultural and Biological Sciences | 4 | 5% |
| Other | 15 | 19% |
| Unknown | 21 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2015.
All research outputs
#18,338,946
of 22,710,079 outputs
Outputs from European Journal of Clinical Pharmacology
#2,216
of 2,552 outputs
Outputs of similar age
#144,927
of 192,813 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#22
of 27 outputs
Altmetric has tracked 22,710,079 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,552 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,813 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.